Type 2 Diabetes
At Medical Center Zdrave Lom EOOD, researchers are investigating novel oral treatments for type 2 diabetes, aiming to improve blood‑sugar management in patients who remain uncontrolled on standard medication.
- Comparison of new therapy versus existing GLP‑1 analogues
- Impact on HbA1c reduction
- Assessment of safety and tolerability
- Potential benefits for weight reduction
The work contributes to advancing metabolic care and offers hope for better long‑term outcomes.
Overweight and Obesity
The site is also conducting studies on overweight and obesity, testing an oral agent combined with lifestyle changes to enhance weight loss in adults.
- Evaluation of weight change with reduced‑calorie diet
- Integration of increased physical activity
- Safety profile of the oral medication
- Improvement in metabolic health markers
These trials align with the centre’s focus on nutritional and metabolic diseases and aim to provide new options for weight management.
